The Business Research Company’s report on the Tissue Microarray Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How are market drivers shaping the future growth trajectory of the tissue microarray industry?
The growing number of cancer cases is expected to propel the growth of the tissue microarray market going forward. Cancer is a category of illnesses that can develop in any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. Tissue arrays are used in oncology to examine the expression of cancer-related biomarkers in various tumor samples. For instance, in June 2022, according to the data published by the Macmillan Cancer Support, a UK-based cancer charity, the number of people living with cancer reached 3 million in 2022 and is projected to rise to nearly 3.5 million by 2025 and 4 million by 2030 in the UK. Therefore, the growing number of cancer cases is driving the growth of the tissue microarray market.
Access Your Free Sample of the Global Tissue Microarray Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp
What is the estimated market size of the tissue microarray sector by 2029, based on current forecasts?
The tissue microarray market size has grown strongly in recent years. It will grow from $12.05 billion in 2024 to $13.23 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to rise of precision medicine, drug discovery and development, efficient analysis, rising prevalence of chronic diseases, biobanking initiatives
The tissue microarray market size is expected to see rapid growth in the next few years. It will grow to $20.95 billion in 2029 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to emergence of digital pathology, expanded applications, growing biopharmaceutical industry, regulatory support and standards, ai and machine learning integration. Major trends in the forecast period include advancements in imaging technologies, development of 3d tissue microarrays, high-content screening, standardization initiatives, and single-cell analysis integration.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12236&type=smp
Who are the top players in the tissue microarray market?
Major companies operating in the tissue microarray market include Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, Dickinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC
What are the major trends in the tissue microarray market?
Strategic partnerships are a key trend gaining popularity in the tissue microarray market. Major companies operating in the tissue microarray market are undergoing partnerships to develop a new relationship in which two or more organizations develop tissue microarray technologies. For instance, in November 2022, The Cureline Group, a US-based translational and precision medicine CRO providing HBS biobanking and laboratory services, partnered with Cellecta Inc., a US-based provider of RNAi and CRISPR screening products and services, to launch Tissue 2 Target Services, a new strategic alliance to combine the companies’ critical competencies in molecular analysis of cells and tissues and human biospecimen management to offer pre-clinical and translational research facilities specializing in gene target and biomarker discovery services that streamline workflows. Furthermore, in September 2022, Ultivue Inc., a US-based biotechnology company that develops reagent-based solutions that maximize the biological information available from cells and tissue samples, partnered with ngTMA, a Switzerland-based Translational Research Unit (TRU) platform of the University of Bern that develops novel workflows for tissue microarray construction. This partnership plans to advance multiplexed immunofluorescence (mIF) assays and apply new TMA technologies to unlock spatial analysis in scientific research and enhance the caliber of TMAs used in clinical and translational research.
Which geography holds the highest tissue microarray market share?
North America was the largest region in the tissue microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report
How do different segments contribute to the overall expansion of the tissue microarray market?
The tissue microarray market covered in this report is segmented –
1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types
2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting
3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics
4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals
Subsegments:
1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry
2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH
3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array
4) By Other Types: Nucleic Acid Microarrays, RNA In Situ Hybridization, Paraffin-Embedded Tissue Array
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12236
How is the tissue microarray market defined?
Tissue microarray refers to high-throughput technology that enables thorough analysis of an antigen’s expression across numerous tissues and cells in a single experiment using paraffin blocks or formalin. Tissue microarrays are used to simultaneously assess the protein expression of multiple tissue samples.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
